$DYAI
Dyadic International, Inc.
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$0.385
▲+1.08%+$0.004
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateDyadic International, Inc.
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is DYAI up today? It is at $0.385 (+1.08%), and our scanner flagged it 2 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment DYAI spikes, and full due diligence on DYAI — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $DYAI 2 times in the last 30 days. Create a free account to track $DYAI, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on DYAI from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for DYAI today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystListing deficiency / delisting riskReverse split plannedStatus pending stockholder approval, from an SEC filing. Read it →Latest filingSC 13GPassive 5%+ stake disclosedOct 15, 2026 · 4 days agoA share sale has already completed, so that supply is out there. Size not stated in the filing.
Some filings did not state a size, so these are floors.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Francisco Trust Under Agreement Dated February 28, 1996 Beneficial Owner (10%) | Sold (automatic/other) | -3K | sold <0.1% | 3.28M | $3K at $1.21 | Jul 24, 26 |
Francisco Trust Under Agreement Dated February 28, 1996 Beneficial Owner (10%) | Sold (automatic/other) | -55K 0.2% of company | sold 1.6% | 3.28M | $71K at $1.30 | Jul 23, 26 |
Francisco Trust Under Agreement Dated February 28, 1996 Beneficial Owner (10%) | Sold (automatic/other) | -38K 0.1% of company | sold 1.1% | 3.34M | $51K at $1.33 | Jul 22, 26 |
Emalfarb Mark A Officer | Acquired (grant/award) | +103K 0.3% of company | added 2.2% | 4.83M | n/a | Jan 2, 26 |
Hazelton Joseph P Officer | Acquired (grant/award) | +36K 0.10% of company | added 23% | 192K | n/a | Jan 2, 26 |
Herbst Seth Director | Other | 22K 0.06% of company | added 12% | 202K | n/a | Jan 2, 26 |
Kaye Jack Director | Other | 22K 0.06% of company | added 36% | 81K | n/a | Jan 2, 26 |
Lucy Patrick K. Director | Other | 22K 0.06% of company | added 42% | 72K | n/a | Jan 2, 26 |
Rawson Ping Wang Officer | Acquired (grant/award) | +29K 0.08% of company | added 21% | 170K | n/a | Jan 2, 26 |
Tchelet Ronen Officer | Acquired (grant/award) | +18K 0.05% of company | added 55% | 51K | n/a | Jan 2, 26 |
Hazelton Joseph P Officer | Bought (open market) | +26K 0.07% of company | added 20% | 155K | $25K at $0.950 | Aug 1, 25 |
Bose Arindam Director | Other | 11K 0.03% of company | added 21% | 62K | n/a | Jun 20, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on DYAI from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for DYAI today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
DYAI last traded at $0.385, up 1.08% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Dyadic International, Inc. (DYAI) is next expected to report earnings on Wednesday, November 11, 2026, about 22 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The DYAI Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged DYAI 2 times in the last 30 days.
DYAI (Dyadic International, Inc.) trades on XNAS, with a market cap of about $14M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge DYAI for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$DYAI discussion
Sign in to ask a question or join the discussion.